Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Drotrecogin alfa (activated) (DrotAA), a recombinant human activated protein C (APC), mitigates smoke-induced elevations in pulmonary microvascular permeability and proinflammatory cytokine IL-1β levels in rats. It also inhibits coagulation and inflammation while enhancing fibrinolysis. Drotrecogin alfa (activated) is applicable in severe sepsis research [1] [2]. |
In vivo | Drotrecogin alfa (activated) administered intravenously at doses up to 20 mg/kg immediately post smoke exposure markedly reduces smoke inhalation injury in a dose-dependent fashion within 2 hours following the event. At a dose of 20 mg/kg, Drotrecogin alfa (activated) enhances the expiratory phase of pulmonary dynamic compliance [2]. |
Cas No. | 98530-76-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.